Focused Ultrasound Thalamotomy for Tremor in Parkinson's Disease: Outcomes in a Large, Prospective Cohort [0.03%]
帕金森病震颤丘脑造瘘术的疗效：一项大规模、前瞻性队列研究的结果
Melissa M J Chua,Sarah E Blitz,Patrick R Ng et al.
Melissa M J Chua et al.
Background: Magnetic resonance guided focused ultrasound (MRgFUS) is United States Food and Drug Administration approved for the treatment of tremor-dominant Parkinson's disease (TdPD), but only limited studies have been ...
Genome-Wide Meta-Analysis of Cerebrospinal Fluid Biomarkers in Alzheimer's Disease and Parkinson's Disease Cohorts [0.03%]
阿尔茨海默病和帕金森病队列中脑脊液生物标志物的全基因组元分析
Michael Ta,Cornelis Blauwendraat,Tarek Antar et al.
Michael Ta et al.
Background: Amyloid-β, phosphorylated tau (p-tau), and total tau (t-tau) in cerebrospinal fluid are established biomarkers for Alzheimer's disease (AD). In other neurodegenerative diseases, such as Parkinson's disease (P...
Shared Genetics and Comorbid Genes of Amyotrophic Lateral Sclerosis and Parkinson's Disease [0.03%]
遗传共性和并存基因的遗传性及帕金森病患者遗传性肌肉萎缩侧索硬化症患者的遗传性及其共患病基因
Ye Tian,Guochen Ma,Haoqi Li et al.
Ye Tian et al.
Background: Comorbidity exists between amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), but the role of genetic factors is unclear. Objec...
Deep Brain Stimulation as an Exclusion Criterion in Parkinson's Disease Studies: Time to Rethink? [0.03%]
帕金森病研究中深部脑刺激作为排除标准的现状及重新评估的时机
Camila Aquino,Lan Luo,Pinky Agarwal et al.
Camila Aquino et al.
As Frequent as Polyglutamine Spinocerebellar Ataxias: SCA27B in a Large German Autosomal Dominant Ataxia Cohort [0.03%]
频繁的多谷氨酰胺脊髓小脑共济失调：德国大型常染色体显性共济失调队列中的SCA27B
Holger Hengel,David Pellerin,Carlo Wilke et al.
Holger Hengel et al.
Cognitive Safety of Cannabis Products in Parkinson's Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds [0.03%]
帕金森病大麻制品的认知安全性：目前尚无定论，亟需科学证据指导医护人员和患者
Travis H Turner,Vanessa K Hinson
Travis H Turner
Michele Tinazzi,Carlo Alberto Artusi
Michele Tinazzi
No Correlation between Plasma GPNMB Levels and Multiple System Atrophy in Chinese Cohorts [0.03%]
中国人群血浆GPNMB水平与多系统萎缩无相关性
Linlin Wan,You Fu,Zhao Chen et al.
Linlin Wan et al.
Background: Glycoprotein nonmetastatic melanoma protein B (GPNMB) has been demonstrated to mediate pathogenicity in Parkinson's disease (PD) through interactions with α-synuclein, and plasma GPNMB tended to be a novel bi...
Basal Forebrain Atrophy, Cortical Thinning, and Amyloid-β Status in Parkinson's disease-Related Cognitive Decline [0.03%]
帕金森病认知功能下降与基底前脑萎缩、皮层变薄和淀粉样蛋白状态的关系
Miguel A Labrador-Espinosa,Jesús Silva-Rodríguez,María Isabel Reina-Castillo et al.
Miguel A Labrador-Espinosa et al.
Background: Degeneration of the cortically-projecting cholinergic basal forebrain (cBF) is a well-established pathologic correlate of cognitive decline in Parkinson's disease (PD). In Alzheimer's disease (AD) the effect o...
Blood-Based α-Synuclein Seeding-A New Era for Identifying Parkinsonian Syndromes [0.03%]
基于血液的α-突触核蛋白病理性沉积检测——识别帕金森综合征的新时代
Max Borsche,Daniela Berg
Max Borsche